Form 8-K - Current report:
SEC Accession No. 0001390478-16-000122
Filing Date
2016-07-18
Accepted
2016-07-18 17:17:07
Documents
1
Period of Report
2016-07-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K gale-201607158xk.htm 8-K 36773
  Complete submission text file 0001390478-16-000122.txt   38167
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 161772052
SIC: 2834 Pharmaceutical Preparations